xeljanz is used for what
Manufactured by Pfizer, Xeljanz is a round, white, immediate-release, film-coated tablet with Pfizer on one side, and JKI5 imprinted on the other side. Xeljanz is the first oral DMARD approved for rheumatoid arthritis in 10 years. It's also the first in a new class of medicines known as JAK (Janus kinase) inhibitors. Xeljanz can be used as monotherapy (alone), or combined with methotrexate or other non-biologic DMARDs. Xeljanz should not be used with biologic drugs or powerful immunosuppressants, such as Imuran (azathioprine) or cyclosporine. How It Works Basically, Xeljanz works by inhibiting the JAK pathway -- a signaling pathway inside cells that plays a significant role in inflammation associated with rheumatoid arthritis.